Khiron Life Sciences Corp. (KHRNF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 25, 2026
Khiron Life Sciences Company Description
Khiron Life Sciences Corp. operates as a medical cannabis company in Latin America and Europe.
It engages in the cultivation, production, distribution, and export of tetrahydrocannabinol medical cannabis products.
The company is also involved in the operation of health centers under the Zerenia and Dr. Zerenia brand names; and provision of medical education and training programs for health professionals.
It sells its products in Colombia, Peru, Germany, the United Kingdom, Brazil, Uruguay, and Mexico. The company is headquartered in Bogota, Colombia.
Khiron Life Sciences Corp.
| Country | Canada |
| Founded | 2012 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Alvaro Torres |
Contact Details
Address: Carrera 11 #84-09 Bogota, BC BC Colombia | |
| Phone | 57 1 744 2064 |
| Website | khiron.ca |
Stock Details
| Ticker Symbol | KHRNF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | CAD |
| ISIN Number | CA49374L3065 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Alvaro Francisco Torres | Co-Founder, Chief Executive Officer and Director |
| Franziska Katterbach | President of Khiron Europe |
| Swapan Kakumanu ACA, ACWA, CGA | Corporate Secretary |
| Michael John O'Connor MA | Chief Financial Officer |
| Marco Algorta | Country Manager of Uruguay |